Skip to content
★ Sign in to follow
HP

Henrik Palm

Annexin Pharmaceuticals AB
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€17k
▼ Sales (0 ops.)
—

Latest filing published 20 Jul 2020 for Annexin Pharmaceuticals AB, €9,081.

Filing timeline

BuySale
Henrik Palm

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Henrik Palm: trading record in brief

Henrik Palm discloses dealings in Annexin Pharmaceuticals AB to Finansinspektionen. Between 3 March 2020 and 17 July 2020, the trades on record add up to 7 filings.

Purchases make up the whole of the open-market record (7 purchases, €17k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

In size, the median ticket on the buying side is €1,232.

The latest filing, published on 20 July 2020, reports an open-market purchase of €9,081 in Annexin Pharmaceuticals AB. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Henrik Palm

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Ekonomi/finanschefExecutivesAnnexin Pharmaceuticals AB
    94,303 SEK0FI-SE
    235,758 shares@ SEK 0.4056.1% of flowTeckningsoptionFI:csv-7bf48d427ee67cd9720d
    Canonical exit: 15 Oct 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesAnnexin Pharmaceuticals AB
    12,000 SEK0FI-SE
    10,000 shares@ SEK 1.206.5% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-c2752bee1889d219bd1e
    Canonical exit: 4 Jun 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesAnnexin Pharmaceuticals AB
    32,500 SEK0FI-SE
    25,000 shares@ SEK 1.3019.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-96edcff076f63dade40a
    Canonical exit: 3 Jun 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesAnnexin Pharmaceuticals AB
    13,000 SEK0FI-SE
    10,000 shares@ SEK 1.307.6% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-90ba01329c3467e13472
    Canonical exit: 3 Jun 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesAnnexin Pharmaceuticals AB
    2,972 SEK0FI-SE
    2,286 shares@ SEK 1.301.7% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-e1d01cde8d9dc3234c17
    Canonical exit: 3 Jun 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesAnnexin Pharmaceuticals AB
    23,400 SEK0FI-SE
    18,000 shares@ SEK 1.3013.6% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-611e582e18d54010bd3f
    Canonical exit: 1 Jun 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesAnnexin Pharmaceuticals AB
    3,420 SEK0FI-SE
    2,714 shares@ SEK 1.262.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-1d3a573db48c01aaf0e4
    Canonical exit: 1 Jun 2020 (T+90)

7 of 7 declarations